252 related articles for article (PubMed ID: 18543280)
61. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
62. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
[TBL] [Abstract][Full Text] [Related]
63. Multigene methylation analysis of conventional renal cell carcinoma.
Onay H; Pehlivan S; Koyuncuoglu M; Kirkali Z; Ozkinay F
Urol Int; 2009; 83(1):107-12. PubMed ID: 19641369
[TBL] [Abstract][Full Text] [Related]
64. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
[TBL] [Abstract][Full Text] [Related]
65. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
66. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
Singh TD; Gupta S; Shrivastav BR; Tiwari PK
Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
[TBL] [Abstract][Full Text] [Related]
67. O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis.
Menigatti M; Pedroni M; Verrone AM; Borghi F; Scarselli A; Benatti P; Losi L; Di Gregorio C; Schär P; Marra G; Ponz de Leon M; Roncucci L
Oncol Rep; 2007 Jun; 17(6):1421-7. PubMed ID: 17487400
[TBL] [Abstract][Full Text] [Related]
68. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
69. Hyperplasia, metaplasia, dysplasia and neoplasia lesions in chronic cholecystitis - a morphologic study.
Stancu M; Căruntu ID; Giuşcă S; Dobrescu G
Rom J Morphol Embryol; 2007; 48(4):335-42. PubMed ID: 18060182
[TBL] [Abstract][Full Text] [Related]
70. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
71. [Natural history of gallbladder cancer. Analysis of biopsy specimens].
Roa E I; Muñoz N S; Ibacache S G; Aretxabala U Xd
Rev Med Chil; 2009 Jul; 137(7):873-80. PubMed ID: 19802413
[TBL] [Abstract][Full Text] [Related]
72. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
[TBL] [Abstract][Full Text] [Related]
73. [K-ras gene mutation in gallbladder carcinoma].
Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
[TBL] [Abstract][Full Text] [Related]
74. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions.
Ramírez N; Bandrés E; Navarro A; Pons A; Jansa S; Moreno I; Martínez-Rodenas F; Zárate R; Bitarte N; Monzó M; García-Foncillas J
Eur J Cancer; 2008 Nov; 44(17):2689-95. PubMed ID: 18938072
[TBL] [Abstract][Full Text] [Related]
75. Frequent methylation of Vimentin in well-differentiated gastric carcinoma.
Kitamura YH; Shirahata A; Sakata M; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jun; 29(6):2227-9. PubMed ID: 19528485
[TBL] [Abstract][Full Text] [Related]
76. Promoter hypomethylation of protease-activated receptor 2 associated with carcinogenesis in the stomach.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Takagi T; Hasegawa S; Wang FY; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Jun; 22(6):943-8. PubMed ID: 17517084
[TBL] [Abstract][Full Text] [Related]
77. WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.
Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y
Gene; 2017 Jul; 622():42-49. PubMed ID: 28438695
[TBL] [Abstract][Full Text] [Related]
78. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
79. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis.
Tahara T; Arisawa T; Shibata T; Yamashita H; Yoshioka D; Hirata I
Anticancer Res; 2009 Jan; 29(1):337-41. PubMed ID: 19331170
[TBL] [Abstract][Full Text] [Related]
80. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
Zhang Q; Jin J; Tao Q
Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
